Monopar Therapeutics, Inc. (MNPR)
114.11
-0.27
(-0.24%)
USD |
NASDAQ |
Sep 09, 14:39
Monopar Therapeutics 1 Year Total Returns (Daily) : 175.7% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 175.7% |
| September 04, 2026 | 202.7% |
| September 03, 2026 | 227.4% |
| September 02, 2026 | 242.7% |
| September 01, 2026 | 244.3% |
| August 31, 2026 | 227.8% |
| August 28, 2026 | 210.3% |
| August 27, 2026 | 227.3% |
| August 26, 2026 | 255.0% |
| August 25, 2026 | 264.3% |
| August 24, 2026 | 247.3% |
| August 21, 2026 | 238.3% |
| August 20, 2026 | 236.0% |
| August 19, 2026 | 269.6% |
| August 18, 2026 | 247.5% |
| August 17, 2026 | 226.2% |
| August 14, 2026 | 215.2% |
| August 13, 2026 | 229.5% |
| August 12, 2026 | 220.1% |
| August 11, 2026 | 265.2% |
| August 10, 2026 | 235.8% |
| August 07, 2026 | 197.3% |
| August 06, 2026 | 195.7% |
| August 05, 2026 | 194.8% |
| August 04, 2026 | 183.7% |
| Date | Value |
|---|---|
| August 03, 2026 | 174.4% |
| July 31, 2026 | 163.1% |
| July 30, 2026 | 168.8% |
| July 29, 2026 | 149.7% |
| July 28, 2026 | 151.4% |
| July 27, 2026 | 145.3% |
| July 24, 2026 | 134.7% |
| July 23, 2026 | 125.5% |
| July 22, 2026 | 148.7% |
| July 21, 2026 | 144.6% |
| July 20, 2026 | 127.8% |
| July 17, 2026 | 135.2% |
| July 16, 2026 | 164.2% |
| July 15, 2026 | 173.4% |
| July 14, 2026 | 128.2% |
| July 13, 2026 | 180.3% |
| July 10, 2026 | 178.6% |
| July 09, 2026 | 158.4% |
| July 08, 2026 | 158.7% |
| July 07, 2026 | 156.0% |
| July 06, 2026 | 167.9% |
| July 02, 2026 | 178.1% |
| July 01, 2026 | 183.2% |
| June 30, 2026 | 158.8% |
| June 29, 2026 | 181.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 74.41% |
| Amgen, Inc. | 44.20% |
| Anika Therapeutics, Inc. | 135.3% |
| BioCryst Pharmaceuticals, Inc. | 10.68% |
| Imunon, Inc. | -73.54% |